Subscribe To
Eos energy: determining fair value based on current backlog and other growth expectations
Eos Energy is developing a novel zinc-based battery system that rivals, and has the potential to disrup...
January 31, 2022, 2:34 pm
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...
January 31, 2022, 5:00 am
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...
January 31, 2022, 5:00 am
Down 57% in a month, is there more pain for tg therapeutics stock?
The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...
January 31, 2022, 5:00 am
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st
CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...
January 30, 2022, 4:00 pm
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st
CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...
January 30, 2022, 4:00 pm
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st
CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...
January 30, 2022, 4:00 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....
January 28, 2022, 1:06 pm
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...
January 27, 2022, 7:29 am
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...
January 27, 2022, 7:29 am
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...
January 27, 2022, 7:29 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...
January 25, 2022, 8:43 am
Ketamineone changes name to wellbeing digital science
KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc. Wellbeing will continue to ...
January 24, 2022, 8:54 am
Ketamineone changes name to wellbeing digital science
KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc. Wellbeing will continue to ...
January 24, 2022, 8:54 am
Ketamineone changes name to wellbeing digital science
KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc. Wellbeing will continue to ...
January 24, 2022, 8:54 am
Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "maximized" its intellectual property (IP) positi...
January 24, 2022, 8:22 am